Sclerosis, Systemic
8 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Multicenter Trial to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of HZN-825 in Patients With Diffuse Cutaneous Systemic Sclerosis (NCT04781543) | Amgen | 2021-11-05 |
| Effects of FT011 in Systemic Sclerosis (NCT04647890) | Certa Therapeutics | 2021-07-19 |
| Prevalence of Hyperprolactinemia in Systemic Scleroderma (NCT04746313) | University Hospital, Lille | 2021-03-01 |
| Pragmatic Clinical Trials in Scleroderma (NCT03610217) | University of West London | 2018-10-01 |
| Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effectiveness for Patients With Systemic Sclerosis With Interstitial Lung Disease (NCT01559129) | Celgene | 2012-08-09 |
| A Study of RoActemra/Actemra (Tocilizumab) Versus Placebo in Patients With Systemic Sclerosis (NCT01532869) | Hoffmann-La Roche | 2012-03-01 |
Track Sclerosis, Systemic automatically
Every clearance here is in the API, with alerts when new ones post.